Warren to lead TRIAD, autism clinical services
Zachary Warren, Ph.D., has been named director of the Vanderbilt Kennedy Treatment and Research Institute for Autism Spectrum Disorders (TRIAD) and of Autism Clinical Services for Vanderbilt Pediatrics' Division of Developmental Medicine.
Warren joined TRIAD four years ago to develop clinical and research structures to better serve individuals with autism spectrum disorders (ASD) and their families.
Zachary Warren, Ph.D.
“Zack has demonstrated time and again how deeply he's committed to helping children with autism and their families,” said Elisabeth Dykens, Ph.D., director of the Vanderbilt Kennedy Center for Research on Human Development, who announced the appointment.
“His appointment will facilitate TRIAD's rapid development into new areas of service, training and research.”
In addition to leading Vanderbilt autism evaluation and diagnostic clinics, Warren also will provide oversight of TRIAD Outreach and Training, in coordination with Nicolette Bainbridge, Ph.D., Outreach and Training director.
“TRIAD is a focal point for providing services and training and conducting research on autism,” Warren said.
“Our mission is to simultaneously advance services for individuals with autism and their families, while advancing our fundamental knowledge of the disorder, including the most effective treatments.
“While I'm very proud to have the responsibility of leading TRIAD, I'm also acutely aware of how much needs to be done for the children, families, schools and communities we serve.”
Warren said research would continue to be an emphasis under his direction.
“Vanderbilt is a local, national, and international leader in autism research,” he said.
“One of my priorities will be enhanced collaboration with Vanderbilt colleagues to streamline recruitment for research participation and to move forward with creating a functional regional database that works as a partnership between families and researchers.”